Purchase this article with an account.
Esfandiar J. Sabet-Peyman, Eli L. Chang; Assessing the Recurrence Patterns of Chalazia Following Incision and Curettage. Invest. Ophthalmol. Vis. Sci. 2011;52(14):736.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the recurrence rate, location, and time interval of chalazia in patients following incision and curettage (I&C) to identify better management strategies in preventing recurrence.
60 patients with a chalazion on a single eyelid refractory to warm compresses who had undergone I&C by one oculoplastic surgeon prior to 2009 were identified retrospectively. All chart notes subsequent to the I&C were reviewed to identify patient age, gender, chalazion recurrence, the number of recurrences, the location of the recurrence (right upper eyelid, right lower eyelid, left upper eyelid, or left lower eyelid), the timing of the recurrence, the need for an additional I&C surgery, and the underlying diagnosis of rosacea.
Of the 60 patients evaluated in the study, 19 or 31.7% of patients experienced a recurrence after their initial I&C. The majority of recurrences, 57.9%, occurred in females and the average age at the time of initial I&C was 57, ranging from 18 to 85. Most chalazia, 69.2%, recurred on the same eyelid as the original and most required another I&C procedure to resolve. Four patients had multiple recurrences necessitating multiple I&Cs. The majority of chalazia, 53.8%, recurred within the first six months following surgery, 15.4% occurred between six months and one year, and 30.8% recurred after one year. One of the 19 patients with recurrence had an underlying diagnosis of rosacea.
Chalazia recurrence is a considerable problem affecting over 30% of patients following I&C as demonstrated by our study and supported by the literature. Few studies, if any, have focused on the location and timing of chalazia recurrences following I&C. Our data demonstrate that the majority of chalazia recur on the same eyelid as the original lesion within the first six months of surgery. Given our results, patients may benefit from closer follow up as well as a localized, multimodal, and staggered treatment strategy using steroids for prevention of chalazia following I&C in the respective eyelid. More studies are necessary to assess the added value of steroid injections following I&C to prevent recurrence.
This PDF is available to Subscribers Only